In this article
The Link Between HIV/AIDS and Cancer Susceptibility
As we all know, our innate immunity plays a major role in the initiation and progression of cancer in the human body, so it does not come as a surprise that HIV / AIDS comes with an increased susceptibility to different types and forms of cancer. AIDS-related cancer refers to any cancer that is more likely to occur in a person who is infected with HIV. The list includes, but is not limited to, Kaposi’s sarcoma (KS), lymphoma, including Non- Hodgkin’s Lymphoma (NHL) and Hodgkin’s Lymphoma (HL / HD), Cervical cancer and cancers of the mouth, throat, liver, lung, and anus. This list can be further extended to angiosarcoma, penile cancer, testicular cancer, colorectal cancer, and different varieties of skin cancer, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. Of these, a trio of cancers, namely, KS, NHL, and cervical cancer, are referred to as AIDS-defining cancers, meaning that the development of any of these cancers in an HIV positive patient signifies the progression of HIV positivity to full blown AIDS. This trio of cancers is described below
Understanding AIDS-Defining Cancers
- Kaposi’s Sarcoma: Kaposi’s sarcoma is a soft tissue sarcoma (sarcoma = cancer arising from the connective tissue of the body), which can be divided into endemic KS and epidemic KS. Endemic KS is unrelated to HIV / AIDS and has been traditionally associated with young African males, those of Jewish or Mediterranean descent, or persons who are on immunosuppressive therapy following an organ transplantation. Epidemic KS is associated with HIV / AIDS and typically, homosexual men with HIV / AIDS associated with Human Herpesvirus (HHV) type 8 infection.
- Non – Hodgkin’s lymphoma: The lymphatic system is a network of lymph vessels and lymph nodes in the human body that carries a colourless ultrafiltrate of the blood called lymph, which typically contains lymphocytes, a type of white blood cell. The lymphatic system has an important role to play in the defence mechanisms of our body. Apart from the lymphatic channels and the lymph nodes, the spleen (filters blood and makes lymphocytes), the thymus, the tonsils, and the bone marrow also form part of the lymphatic system. NHL is a type of cancer of the lymphatic system where the healthy cells of the lymphatic system multiply rapidly, grow out of control, and may or may not form a tumour. Although there are many different types of NHL, the ones that are most commonly associated with HIV / AIDS are aggressive B cell lymphomas, especially diffuse large B cell lymphoma (DLBCL) and Burkitt’s lymphoma; primary central nervous system lymphoma (primary CNS lymphoma) affecting the brain; and primary effusion lymphoma, which causes fluid accumulation around the lungs (pleural effusion), heart (pericardial effusion), and abdominal cavity (ascites).
- Cervical cancer / cancer of the uterine cervix: The uterine cervix, commonly known as the cervix, is the lowermost part of the uterus, which projects out into the vaginal cavity and thus forms the birth canal. Women with HIV / AIDS have a higher propensity to develop a precancerous condition of the cervix known as cervical intraepithelial neoplasia (CIN). There are different grades of CIN and its association with the Human Papilloma Virus (HPV); mainly types 16 and 18, has been proved conclusively. A high grade CIN (CIN – III) can progress to invasive cervical cancer. Typically, it takes decades for a CIN to progress to invasive cervical cancer, but a co-infection with HIV / AIDS can hasten the process of development and progression to invasive cancer by a mere few years.
The management and treatment of AIDS – related cancers is no different from accepted treatment protocols for these cancers without the association of HIV / AIDS but we have to additionally treat the HIV / AIDS simultaneously and be extra vigilant about the additional immunosuppression due to the cancer, the disease (HIV / AIDS) and that induced by the treatment.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

About Sai Sree
✓ Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.
